JP2007523640A5 - - Google Patents

Download PDF

Info

Publication number
JP2007523640A5
JP2007523640A5 JP2006550132A JP2006550132A JP2007523640A5 JP 2007523640 A5 JP2007523640 A5 JP 2007523640A5 JP 2006550132 A JP2006550132 A JP 2006550132A JP 2006550132 A JP2006550132 A JP 2006550132A JP 2007523640 A5 JP2007523640 A5 JP 2007523640A5
Authority
JP
Japan
Prior art keywords
axotrophin
polypeptide
polynucleotide
derived
encoded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006550132A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007523640A (ja
Filing date
Publication date
Priority claimed from GBGB0402051.7A external-priority patent/GB0402051D0/en
Application filed filed Critical
Publication of JP2007523640A publication Critical patent/JP2007523640A/ja
Publication of JP2007523640A5 publication Critical patent/JP2007523640A5/ja
Withdrawn legal-status Critical Current

Links

JP2006550132A 2004-01-29 2005-01-31 免疫応答を誘導または調節する方法 Withdrawn JP2007523640A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0402051.7A GB0402051D0 (en) 2004-01-29 2004-01-29 Fate determination in immunity
PCT/EP2005/000934 WO2005074973A2 (en) 2004-01-29 2005-01-31 Method of inducing or modulating immune response

Publications (2)

Publication Number Publication Date
JP2007523640A JP2007523640A (ja) 2007-08-23
JP2007523640A5 true JP2007523640A5 (https=) 2008-03-21

Family

ID=31971742

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006550132A Withdrawn JP2007523640A (ja) 2004-01-29 2005-01-31 免疫応答を誘導または調節する方法

Country Status (10)

Country Link
US (2) US20070286807A1 (https=)
EP (1) EP1713495A2 (https=)
JP (1) JP2007523640A (https=)
KR (1) KR20070007291A (https=)
CN (1) CN1929855A (https=)
AU (1) AU2005210105A1 (https=)
CA (1) CA2560055A1 (https=)
GB (1) GB0402051D0 (https=)
WO (1) WO2005074973A2 (https=)
ZA (1) ZA200606331B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402051D0 (en) * 2004-01-29 2004-03-03 Metcalfe Su Fate determination in immunity
DK1826279T3 (da) * 2006-02-28 2011-09-05 Charite Universitaetsmedizin Detektering og kvalitetskontrol af regulatoriske t-celler vha. DNA-metyleringsanalyse af FoxP3--genet
GB0614536D0 (en) * 2006-07-21 2006-08-30 Metcalfe Susan M Methods of controlling cellular response to LIF
GB0721081D0 (en) * 2007-10-26 2007-12-05 Metcalfe Susan M Immuno-modulatory composition
CA2770237A1 (en) * 2009-08-05 2011-02-10 Nexigen Gmbh Human hcv-interacting proteins and methods of use
WO2014031883A1 (en) 2012-08-23 2014-02-27 Susan Marie Metcalfe Neurotherapeutic nanoparticle compositions and devices
US11369473B2 (en) 2019-04-08 2022-06-28 Loubert S. Suddaby Extended release immunomodulatory implant to facilitate bone morphogenesis
US11779683B2 (en) * 2019-04-08 2023-10-10 Loubert S. Suddaby Extended release immunomodulatory implant to facilitate bone morphogenesis
CN112843222B (zh) * 2021-01-21 2023-01-31 暨南大学 Ankrd22蛋白在制备治疗或延缓自身免疫性疾病的产品中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
US6783969B1 (en) * 2001-03-05 2004-08-31 Nuvelo, Inc. Cathepsin V-like polypeptides
AU2003213606A1 (en) * 2002-03-01 2003-10-13 Exelixis, Inc. MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
GB0402051D0 (en) * 2004-01-29 2004-03-03 Metcalfe Su Fate determination in immunity

Similar Documents

Publication Publication Date Title
JP6526870B2 (ja) 乳がんの検出を補助する方法、ポリペプチドプローブセット、およびポリヌクレオチドアレイ
CN105556308B (zh) 用于阑尾炎的诊断和预后及腹痛病因的区分的方法和组合物
CN109661578A (zh) 用于区分细菌和病毒感染的蛋白质特征
JP2010539508A5 (https=)
EP3298160B1 (en) Method for predicting the response of melanoma patients to targeted pharmacotherapy
JP2017506623A5 (https=)
JP2013507641A (ja) 黒色腫腫瘍細胞の識別のためのバイオマーカー
JP2009540803A5 (https=)
KR20120093298A (ko) 티보자닙 반응 예측
CN104422768A (zh) 一种联合检测早期卵巢癌标志物的抗体芯片试剂盒
JP2007523640A5 (https=)
JP2007533985A5 (https=)
JP6276992B2 (ja) 胸膜中皮腫患者の早期発見のための分子マーカー及びその発現解析方法
CN107850589A (zh) 13+/17+bin1表达作为心脏病症的标记
JP2021524576A (ja) がんの診断及び治療のための組成物及び方法
CN111936522B (zh) 新型抗胸苷激酶抗体
WO2003000925A1 (en) Methods to identify signal sequences
CN108738347B (zh) 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒
US20120190563A1 (en) Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
WO2018119003A1 (en) Virus composite biosensor
US20120115745A1 (en) Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
CN109633165A (zh) 抗hspa4自身抗体作为乳腺癌诊断或预后评估标志物的应用
Harris et al. Affibodies as an alternative to antibodies in biosensors for cancer markers
CA2486119A1 (en) Method of isolating an endothelial cell and method of donor specific crossmatching
JP5428004B2 (ja) 消化管間質腫瘍を患う患者の予後を予測するためのキット